121 related articles for article (PubMed ID: 15547724)
1. Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo.
Hu X; Washington S; Verderame MF; Demers LM; Mauger D; Manni A
Int J Oncol; 2004 Dec; 25(6):1831-8. PubMed ID: 15547724
[TBL] [Abstract][Full Text] [Related]
2. CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity.
Regenass U; Mett H; Stanek J; Mueller M; Kramer D; Porter CW
Cancer Res; 1994 Jun; 54(12):3210-7. PubMed ID: 8205541
[TBL] [Abstract][Full Text] [Related]
3. Role of non-receptor and receptor tyrosine kinases (TKs) in the antitumor action of alpha-difluoromethylornithine (DFMO) in breast cancer cells.
Xu H; Washington S; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Nov; 112(2):255-61. PubMed ID: 18097746
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.
Matters GL; Manni A; Bond JS
Clin Exp Metastasis; 2005; 22(4):331-9. PubMed ID: 16170669
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
6. Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture.
Glikman P; Manni A; Demers L; Bartholomew M
Cancer Res; 1989 Mar; 49(6):1371-6. PubMed ID: 2493979
[TBL] [Abstract][Full Text] [Related]
7. Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts.
Kremmer T; Pälyi I; Daubner D; Boldizsár M; Vincze B; Paulik E; Sugár J; Pokorny E; Túry E
Anticancer Res; 1991; 11(5):1807-13. PubMed ID: 1768053
[TBL] [Abstract][Full Text] [Related]
8. A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.
Siu LL; Rowinsky EK; Hammond LA; Weiss GR; Hidalgo M; Clark GM; Moczygemba J; Choi L; Linnartz R; Barbet NC; Sklenar IT; Capdeville R; Gan G; Porter CW; Von Hoff DD; Eckhardt SG
Clin Cancer Res; 2002 Jul; 8(7):2157-66. PubMed ID: 12114416
[TBL] [Abstract][Full Text] [Related]
9. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2008 Jan; 107(1):33-40. PubMed ID: 17333337
[TBL] [Abstract][Full Text] [Related]
10. Effects of polyamine synthesis inhibitors on primary tumor features and metastatic capacity of human breast cancer cells.
Manni A; Washington S; Hu X; Griffith JW; Bruggeman R; Demers LM; Mauger D; Verderame MF
Clin Exp Metastasis; 2005; 22(3):255-63. PubMed ID: 16158253
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
[TBL] [Abstract][Full Text] [Related]
12. 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit proliferation of estrogen receptor-negative breast cancer cells by activation of multiple pathways.
Vanderlaag K; Su Y; Frankel AE; Grage H; Smith R; Khan S; Safe S
Breast Cancer Res Treat; 2008 May; 109(2):273-83. PubMed ID: 17624585
[TBL] [Abstract][Full Text] [Related]
13. Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells.
Jun JY; Griffith JW; Bruggeman R; Washington S; Demers LM; Verderame MF; Manni A
Breast Cancer Res Treat; 2007 Sep; 105(1):29-36. PubMed ID: 17143592
[TBL] [Abstract][Full Text] [Related]
14. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells.
Wallick CJ; Gamper I; Thorne M; Feith DJ; Takasaki KY; Wilson SM; Seki JA; Pegg AE; Byus CV; Bachmann AS
Oncogene; 2005 Aug; 24(36):5606-18. PubMed ID: 16007177
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and growth-modulatory effects of the new S-adenosylmethionine decarboxylase inhibitor CGP 48664 in malignant and immortalized normal human breast epithelial cells in culture.
Manni A; Badger B; Wechter R; Kunselman S; Rossini A; Demers L
Int J Cancer; 1995 Aug; 62(4):485-91. PubMed ID: 7635576
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity.
Schäfer B; Hauber I; Bunk A; Heukeshoven J; Düsedau A; Bevec D; Hauber J
J Infect Dis; 2006 Sep; 194(6):740-50. PubMed ID: 16941339
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664.
Kramer DL; Black JD; Mett H; Bergeron RJ; Porter CW
Cancer Res; 1998 Sep; 58(17):3883-90. PubMed ID: 9731498
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the polyamine pathway in antiestrogen-induced growth inhibition of human breast cancer.
Cohen FJ; Manni A; Glikman P; Bartholomew M; Demers L
Cancer Res; 1988 Dec; 48(23):6819-25. PubMed ID: 3180091
[TBL] [Abstract][Full Text] [Related]
19. Rhein lysinate suppresses the growth of breast cancer cells and potentiates the inhibitory effect of Taxol in athymic mice.
Lin YJ; Zhen YS
Anticancer Drugs; 2009 Jan; 20(1):65-72. PubMed ID: 19343002
[TBL] [Abstract][Full Text] [Related]
20. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
